"Stacy is joining Upstream Bio at a pivotal time in our growth as we prepare to initiate a third clinical program for ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter ...

Invivyd Inc (IVVD) reports a 15% reduction in operating expenses and explores new viral targets, while navigating sales transitions and regulatory hurdles.

Katie Falzone; Senior Vice President, Finance; Invivyd Inc. Marc Elia; Independent Chairman of the Board; Invivyd Inc. Tim Lee; Chief Commercial Officer; Invivyd Inc ...

Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsKatie Falzone - Senior Vice President, ...

MEC175xB controllers are currently available as part of Microchip's early adopter program. For additional information, ...

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales forcePEMGARDA revenue ...

Analysts are estimating that Invivyd will report an earnings per share (EPS) of $-0.01. Invivyd bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide ...